# FDA recall D-1006-2019

> **Teva Pharmaceuticals USA** · Class III · drug recall initiated 2019-03-11.

## Product

Lansoprazole Delayed-Release Orally Disintegrating Tablets, 15 mg, 100 tablets (10 blister cards of 10 tablets each), Rx only, Manufactured in Israel By: Teva Pharmaceutical Ind. Ltd. Jerusalem, 9777402,  Israel, Manufactured for: Teva Pharmaceuticals USA, Inc. North Wales, PA 19454, NDC 0093-3008-93

## Reason for recall

Subpotent Drug.

## Distribution

Nationwide in the United States.

## Key facts

- **Recall number:** D-1006-2019
- **Recalling firm:** Teva Pharmaceuticals USA
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2019-03-11
- **Report date:** 2019-03-27
- **Termination date:** 2019-11-15

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** North Wales, PA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1006-2019

## Citation

> AI Analytics. FDA recall D-1006-2019. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-1006-2019. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*